Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4/A Shares withheld for taxes Interim CEO gave up 6,356 shares (to pay taxes)
  5. 4 Option exercise Director acquired 8,437 shares (option exercise)
  6. 4 Option exercise Director acquired 5,000 shares (option exercise)
  7. 4 Option exercise Director acquired 5,157 shares (option exercise)
  8. 4 Option exercise Director acquired 5,937 shares (option exercise)
  9. 4 Option exercise Director acquired 4,844 shares (option exercise)
  10. 4 Option exercise Interim CEO & President acquired 20,000 shares (option exercise)
  11. 4 Option exercise Director acquired 5,312 shares (option exercise)
  12. 4/A Option exercise Director acquired 4,844 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Option exercise Director acquired 5,313 shares (option exercise)
  18. 4 Option exercise Director acquired 5,938 shares (option exercise)
  19. 4 Option exercise Director acquired 5,156 shares (option exercise)
  20. 4 Option exercise Director acquired 8,438 shares (option exercise)

Page 3 of 28 · 551 filings